Innoviva, Inc. (INVA)
20.82
+0.11
(+0.53%)
USD |
NASDAQ |
Dec 10, 13:04
Innoviva Market Cap: 1.557B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 170.14B |
| Eli Lilly & Co. | 889.92B |
| Merck & Co., Inc. | 241.70B |
| Pfizer Inc. | 145.21B |
| Bristol Myers Squibb Co. | 103.95B |
Market Cap Related Metrics
| PE Ratio | 14.94 |
| PS Ratio | 4.092 |
| PEG Ratio | 0.1455 |
| Price to Book Value | 1.541 |
| Price to Free Cash Flow | 8.377 |
| Price | 20.82 |
| Earnings Yield | 6.70% |
| PEGY Ratio | 0.1455 |
| Operating PE Ratio | 9.807 |
| Normalized PE Ratio | 12.09 |